awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50292216-756EB8C7-9520-408D-B8EB-3B7CAC7EBF14
Q50292216-756EB8C7-9520-408D-B8EB-3B7CAC7EBF14
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50292216-756EB8C7-9520-408D-B8EB-3B7CAC7EBF14
The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors.
P2860
Q50292216-756EB8C7-9520-408D-B8EB-3B7CAC7EBF14
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50292216-756EB8C7-9520-408D-B8EB-3B7CAC7EBF14
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
af48ce88676cfff02656a5f66eff11f25ee29cf0
P2860
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.